Stocks rebounded over the past week as comments from President Trump eased investor concerns about an escalating trade war ...

Eli Lilly (NYSE:LLY) is a pharmaceutical titan with an $815 billion market cap, putting it on track to be the next $1 ...

Eli Lilly's Orforglipron shines in Phase III trials, potentially leading diabetes and obesity treatment by 2026. See what to ...

Policymakers have moved slowly to reduce regulatory overlap, but the new industry plea could help change that.

Ithaka’s performance lagged the R1000G by 30bps, -10.3% to -10.0% (gross), in a decisively negative market. Click here to ...